Smith & Wesson Brands (SWBI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Dec, 2025Executive summary
Net sales for Q2 fiscal 2026 were $124.7 million, down 3.9% year-over-year, with gross margin at 24.3% versus 26.6% last year.
Net income was $1.9 million ($0.04/share), compared to $4.5 million ($0.10/share) in the prior year; adjusted EBITDAS was $15.1 million (12.1% of sales).
New products accounted for 38.7% of sales, driving market share gains and positive retail sell-through.
Operating cash flow for Q2 was $27.3 million, a significant improvement from a $7.4 million outflow last year.
Inventory management led to a significant reduction, generating strong cash flow.
Financial highlights
Handgun sales for the quarter were $90.8 million (down 3.2%), long gun sales $24.7 million (down 1.8%), and other products/services revenue dropped 14.1%.
Gross profit for Q2 was $30.3 million, down from $34.5 million last year; operating income was $4.1 million, down from $7.5 million.
Free cash flow for Q2 was $19.9 million, up from negative $10.7 million last year.
Cash and cash equivalents at period end were $22.4 million; borrowings outstanding were $90 million on the revolving line of credit.
Average selling prices increased: handguns up 2.1% to $418, long guns up 10.2% to $602.
Outlook and guidance
Q3 sales are expected to be 8–10% higher than Q3 fiscal 2025, with no significant channel inventory impact anticipated.
Q3 gross margins anticipated to increase sequentially and year-over-year.
Q4 projected to see high single-digit to low double-digit growth over Q3.
Operating expenses in Q3 expected to rise about 15% due to SHOT Show, new product development, promotions, and profit sharing.
Inventory levels are expected to decline further during the remainder of the fiscal year.
Latest events from Smith & Wesson Brands
- Q3 net sales up 17.1% to $135.7M, with higher margins and strong Q4 outlook.SWBI
Q3 20265 Mar 2026 - Double-digit growth in revenue and net income, with 2025 outlook for continued gains and higher dividends.SWBI
Q4 20243 Feb 2026 - Q1 sales fell 22.7%, but new products and margin gains support a positive full-year outlook.SWBI
Q1 202522 Jan 2026 - Board re-elections, executive pay approval, and strong financial growth highlighted the meeting.SWBI
AGM 202420 Jan 2026 - Q2 sales up 3.8% to $129.7M, but guidance cut as inflation softens demand and margins.SWBI
Q2 202511 Jan 2026 - Q3 sales fell 15.7% as new products drove 41% of revenue, but margins and sales remain pressured.SWBI
Q3 202527 Dec 2025 - Director elections, say-on-pay, and a human rights proposal headline a governance-focused agenda.SWBI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SWBI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and performance.SWBI
Proxy Filing1 Dec 2025